BA.5 variant detected in the Netherlands The BA.5 variant of the coronavirus SARS-CoV-2 was detected for the first time in the Netherlands this week.
People with impaired immunity invited for repeat vaccination From 19 April on, people who have moderately or severely impaired immunity will receive their invitation for a repeat vaccination against COVID-19.
Most reports received by MEBI in 2021 concerned copper IUDs More reports of suspected adverse effects from copper intrauterine devices (IUDs) were made in 2021 than in previous years, according to the annual report of the Dutch reporting and expertise centre for adverse effects of medical implants (MEBI).
RIVM recalls fill needles for COVID-19 vaccination at supplier’s request As of today, RIVM is recalling the fill needles made by MLS/Sol-Millenium Europe as a precaution, following a safety alert from the supplier. This applies to the SOL-M™ Blunt Fill Needle (REF 110022, LOT 05103013).
Collaboration necessary to ensure the safe reuse of consumer products In a circular economy, products, materials and raw materials are continually reused. For example, consumer products like clothes, packaging and toys.
Patient in Radboudumc not contaminated with the Ebola virus The patient, who was admitted in the Radboud univerisity medical center over the past few days because of a suspected Ebola infection, was proven not to be infected.
Outbreak of avian influenza A (H5N8) in Dutch poultry In November 2014 avian ‘flu has been detected on poultry farms in the Netherlands.
Promising biobased alternatives to substances of very high concern There are many possible biobased alternatives to substances of very high concern (SVHC). Some are even ready to be deployed right away.
European Antibiotic Awareness Day 2014 Tuesday 18 November is European Antibiotic Awareness Day. On this day, throughout Europe, attention is focused on the responsible use of antibiotics for people and animals.
Partnering as effective strategy to bring new drugs to European market Combining strengths in drug discovery and development by partnering with a medium- or large-sized pharmaceutical company increases the likelihood of success in bringing new products to the market f